Use access key #2 to skip to page content.
$10.27 -0.63 (-5.78%)
1/9/2009 4:00 PM

Alkermes, Inc. (ALKS)

CAPS Rating:
****

A biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease.

View All Commentary (ALKS)

Recs

0

Avatar hihoterry (< 20) Submitted: 4/18/07 4:18 PM : Outperform Start Price: $16.55 ALKS Score: 1.24

rising sales of vivitrol, good pipe line and continued expansion of sales in other marketed products

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links